DM
Therapeutic Areas
Shields Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Psilocybin | Treatment‑Resistant Depression | Preclinical |
| MDMA | Post‑Traumatic Stress Disorder | Preclinical |
| Ketamine | Chronic Pain | Preclinical |
| LSD | Substance Use Disorder | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Psilocybin | Treatment‑Resistant Depression | Preclinical |
| MDMA | Post‑Traumatic Stress Disorder | Preclinical |
| Ketamine | Chronic Pain | Preclinical |
| LSD | Substance Use Disorder | Preclinical |